Evidence map›Paper›PMID 36007846›Full record

ArticleMicrobial pathogenesis2022

Evaluating the ability of the NLHA2 and artificial neural network models to predict COVID-19 severity, and comparing them with the four existing scoring systems.

Yue Dong, Kai Wang, Xu Zou, Xiaoping Tan, Yi Zang, Xinyu Li, Xiaoting Ren, Desheng Xie, Zhijun Jie, Xiaohua Chen and 2 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Microbial pathogenesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Controlling nosocomial transmission of respiratory infections in neurological wards: insights from COVID-19 pandemic data.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Yue DongDepartment of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China; Lingang Laboratory, Shanghai, 200031, China.
Kai WangDepartment of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China.
Xu ZouIntensive Care Unit, Guangzhou Hospital of Traditional Chinese Medicine, 111 Dade Road, Yuexiu District, Guangzhou, Guangdong Province, 510000, China.
Xiaoping TanDepartment of Respiratory Medicine, Hubei Jingzhou Jiangling People's Hospital, 29 Chujiang Dadao, Jiangling County, Jingzhou City, Hubei Province, 434101, China.
Yi ZangLingang Laboratory, Shanghai, 200031, China.
Xinyu LiDepartment of Infectious Disease, Gongli Hospital of Shanghai Pudong New Area, 219 Miaopu Road, Pudong New Area, Shanghai, 200120, China.
Xiaoting RenDepartment of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China.
Desheng XieDepartment of Infectious Disease, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China.
Zhijun JieDepartment of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China.
Xiaohua ChenDepartment of Infectious Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Xuhui District, Shanghai, 200030, China.
Yingying ZengDepartment of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai, 200032, China. Electronic address: ying.respire@foxmail.com.
Jindong ShiDepartment of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, 801 Heqing Road, Minhang District, Shanghai, 200240, China. Electronic address: shijindong@5thhospital.com.
Fudan University · CNFirst People's Hospital of Jingzhou · CNGuangdong Provincial Hospital of Traditional Chinese Medicine · CNShanghai Pudong New Area Gongli Hospital · CNShanghai Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To improve the identification and subsequent intervention of COVID-19 patients at risk for ICU admission, we constructed COVID-19 severity prediction models using logistic regression and artificial neural network (ANN) analysis and compared them with the four existing scoring systems (PSI, CURB-65, SMARTCOP, and MuLBSTA). In this prospective multi-center study, 296 patients with COVID-19 pneumonia were enrolled and split into the General-Ward-Care group (N = 238) and the ICU-Admission group (N = 58). The PSI model (AUC = 0.861) had the best results among the existing four scoring systems, followed by SMARTCOP (AUC = 0.770), motified-MuLBSTA (AUC = 0.761), and CURB-65 (AUC = 0.712). Data from 197 patients (training set) were analyzed for modeling. The beta coefficients from logistic regression were used to develop a severity prediction model and risk score calculator. The final model (NLHA2) included five covariates (consumes alcohol, neutrophil count, lymphocyte count, hemoglobin, and AKP). The NLHA2 model (training: AUC = 0.959; testing: AUC = 0.857) had similar results to the PSI model, but with fewer variable items. ANN analysis was used to build another complex model, which had higher accuracy (training: AUC = 1.000; testing: AUC = 0.907). Discrimination and calibration were further verified through bootstrapping (2000 replicates), Hosmer-Lemeshow goodness of fit testing, and Brier score calculation. In conclusion, the PSI model is the best existing system for predicting ICU admission among COVID-19 patients, while two newly-designed models (NLHA2 and ANN) performed better than PSI, and will provide a new approach for the development of prognostic evaluation system in a novel respiratory viral epidemic.

Indexed as

Community-Acquired InfectionsCOVID-19HumansNeural Networks, ComputerPrognosisProspective StudiesRetrospective StudiesCOVID-19CURB-65Machine learningMuLBSTAPSISMARTCOP

Identifiers

PMID36007846
PMCPMC9395227
OpenAlexW4292686788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.